RU94038427A - Peptides, conjugates, pharmaceutical compositions, treatment methods, identification method - Google Patents
Peptides, conjugates, pharmaceutical compositions, treatment methods, identification methodInfo
- Publication number
- RU94038427A RU94038427A RU94038427/14A RU94038427A RU94038427A RU 94038427 A RU94038427 A RU 94038427A RU 94038427/14 A RU94038427/14 A RU 94038427/14A RU 94038427 A RU94038427 A RU 94038427A RU 94038427 A RU94038427 A RU 94038427A
- Authority
- RU
- Russia
- Prior art keywords
- peptides
- hbv
- pharmaceutical compositions
- treatment
- antigens
- Prior art date
Links
Abstract
FIELD: organic chemistry, peptides. SUBSTANCE: peptides stimulating cytotoxic T-lymphocytes induce HLA-limited reactions to hepatitis B virus antigens. Peptides obtained from CTL-epitopic sites both of HBV-surface and nucleocapside antigens are useful for treatment and prevention HBV infection involving treatment of chronically infected HBV carriers. Peptides can be as vaccines and pharmaceutical compositions, for example, lipid-containing compositions to enhance HLA-limited CTL reactions. Peptides are useful also for diagnostic procedures, for prediction of chronic infection form tendency development in HBV-infected persons. EFFECT: enhanced effectiveness of peptides proposed.
Claims (1)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74956891A | 1991-08-26 | 1991-08-26 | |
US827682 | 1992-01-29 | ||
US874491 | 1992-04-27 | ||
US749568 | 1996-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU94038427A true RU94038427A (en) | 1996-10-20 |
Family
ID=25014281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94038427/14A RU94038427A (en) | 1991-08-26 | 1992-08-26 | Peptides, conjugates, pharmaceutical compositions, treatment methods, identification method |
Country Status (2)
Country | Link |
---|---|
RU (1) | RU94038427A (en) |
ZA (1) | ZA926441B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2469044C2 (en) * | 2006-10-17 | 2012-12-10 | Онкотерапи Сайенс, Инк. | Peptide vaccines for cancer expressing mphosph1 or depdc1 polypeptides |
US9458447B2 (en) | 2011-08-12 | 2016-10-04 | Oncotherapy Science, Inc. | MPHOSPH1 peptides and vaccines including the same |
US10676508B2 (en) | 2015-08-12 | 2020-06-09 | Oncotherapy Science, Inc. | DEPDC1-derived peptide and vaccine containing same |
-
1992
- 1992-08-26 RU RU94038427/14A patent/RU94038427A/en unknown
- 1992-08-26 ZA ZA926441A patent/ZA926441B/en unknown
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2469044C2 (en) * | 2006-10-17 | 2012-12-10 | Онкотерапи Сайенс, Инк. | Peptide vaccines for cancer expressing mphosph1 or depdc1 polypeptides |
US8552146B2 (en) | 2006-10-17 | 2013-10-08 | Oncotherapy Science, Inc. | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
US8557955B2 (en) | 2006-10-17 | 2013-10-15 | Oncotherapy Science, Inc. | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
US8653234B2 (en) | 2006-10-17 | 2014-02-18 | Oncotherapy Science, Inc. | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
US9017688B2 (en) | 2006-10-17 | 2015-04-28 | Oncotherapy Science, Inc. | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
US9545437B2 (en) | 2006-10-17 | 2017-01-17 | Oncotherapy Science, Inc. | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
US9458447B2 (en) | 2011-08-12 | 2016-10-04 | Oncotherapy Science, Inc. | MPHOSPH1 peptides and vaccines including the same |
US10676508B2 (en) | 2015-08-12 | 2020-06-09 | Oncotherapy Science, Inc. | DEPDC1-derived peptide and vaccine containing same |
US11673915B2 (en) | 2015-08-12 | 2023-06-13 | Oncotherapy Science, Inc. | DEPDC1-derived peptide and vaccine containing same |
Also Published As
Publication number | Publication date |
---|---|
ZA926441B (en) | 1993-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1018344A3 (en) | HLA-restricted hepatitis B virus CTL epitopes | |
CN1072963C (en) | Vaccine compositions | |
ATE277633T1 (en) | PREPARATIONS AND METHODS FOR TRIGGERING CTL IMMUNITY | |
EP0726758A4 (en) | Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus | |
DE69233607D1 (en) | Peptides that induce the cytotoxic T lymphocyte response to hepatitis B virus | |
ES2176232T3 (en) | ADEQUATE VACCINE TO BE USED IN THE PREVENTION AND TREATMENT OF INFECTION WITH HELICOBACTER. | |
EP1375511A3 (en) | Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus | |
RU94040856A (en) | Vaccine for oral administration | |
RU94038427A (en) | Peptides, conjugates, pharmaceutical compositions, treatment methods, identification method | |
ATE285791T1 (en) | VACCINE CONTAINING ACEMANNAN AS AN ADJUVANT | |
DE3854857T2 (en) | PREVENTION AND TREATMENT OF RETROVIRUS DISEASE | |
ATE111485T1 (en) | PEPTIDE TREATMENT OF PERSISTENT INFECTIOUS DISEASES. | |
CN102085366B (en) | Compound vaccine adjuvant | |
Hayashi et al. | Evaluating the immune responses stimulated by CpG oligodeoxynucleotides | |
DK0542895T3 (en) | Cross-reactive influenza A immunization | |
CA2156416A1 (en) | Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus | |
Semenenko et al. | Enhancement of the immune response to hepatitis B surface antigen by methyl inosine monophosphate | |
RU98105627A (en) | VACCINES | |
CN1882359A (en) | Pharmaceutical compositions for therapeutic use | |
Chuikova et al. | The results of research of reactogenity and immunologic efficacy of hepatitis A and B with purified concentrated adsorbed liquid" HEP-A+ B-in-VAC" vaccine | |
BE837603A (en) | INFLUENZA VACCINE CONTAINING PURIFIED NEURAMINIDASE AS AN ANTIGEN AND PROCESS FOR ADMINISTERING IT |